The sales of Cardiac Glycosides in Italy are projected to remain stable at 0.1 US Dollars Per Capita from 2024 through 2028. The data does not show any year-on-year percentage change given the consistent value forecasted over the years. Without specific volume or value figures for 2023, we assume stability in market dynamics without notable growth or decline.

Trends to watch for in the future include:

Potential advancements in cardiac treatment that could impact Cardiac Glycosides demand.
Regulatory changes in the pharmaceutical sector affecting drug distribution.
Adjustments in healthcare policies and their influence on patient access to cardiac medications.